Across the country, a new policy debate is emerging around kratom, a plant native to Southeast Asia, and one of its naturally occurring alkaloids, 7-hydroxymitragynine, often called 7-OH. Commonly described as having pain-relieving and mood-altering effects, states including Florida and Ohio are now considering or implementing restrictions that could effectively ban products containing the compound. On the surface, such proposals may appear to be well-intentioned, but they risk repeating a familiar mistake: substituting prohibition for thoughtful governance.
At its core this is not a debate about kratom use itself, but about the fundamental principles of individual liberty. Competent adults should have the sovereign right to make their own decisions about what they ingest, free from government intrusion, provided they do not harm others. Americans routinely make decisions involving alcohol, tobacco, dietary supplements, and countless other products that have the potential for adverse effects. We regulate those markets to promote transparency and safety and do not typically ban them outright simply because risks exist.
History suggests that prohibition rarely achieves its intended goals. Alcohol prohibition in the early twentieth century did not eliminate drinking; it empowered organized crime and reduced product safety. More recently, aggressive crackdowns on prescription opioids have left many legitimate pain patients struggling to access needed medication while shifting demand rather than eliminating it. As illicitly produced fentanyl and other synthetic opioids filled that vacuum, the consequences have been tragic.
Kratom itself occupies a complicated space. Millions of Americans report using it for pain management or as a harm-reduction alternative to opioids, although scientific research remains incomplete and ongoing. At the same time, products containing kratom alkaloids are already widely available through established retail channels, reflecting a level of consumer demand that policymakers cannot simply wish away. That reality argues for careful regulation rather than hasty prohibition. A Schedule I–style ban — the same classification used for substances with no accepted medical use — risks shutting down legitimate research just when more evidence is needed and could disrupt an existing marketplace without necessarily reducing demand.
Instead of continuing down this misguided path, lawmakers contemplating bans would better serve their constituents by considering policy frameworks that emphasize accountability, transparency, and consumer choice.
That begins with setting clear age restrictions, ensuring that minors cannot access these products. It continues with independent laboratory testing so consumers know exactly what they are purchasing and so contaminants can be identified before products reach store shelves. Accurate labeling requirements, including disclosure of 7-OH content and serving information, would further help adults make informed decisions. On the enforcement side, genuinely harmful conduct should be targeted: adulteration, mislabeling, counterfeit products, or sales to minors. Those behaviors create public health risks regardless of the underlying substance and deserve serious penalties.
This approach aligns with the traditional principles of limited government for which Republicans stand. It respects individual liberty while recognizing that markets function best when consumers have reliable information and bad actors face consequences. It also avoids pushing economic activity into illicit channels that generate no tax revenue, create enforcement burdens, and undermine product safety.
There is also a broader political consideration that our elected officials should consider. Voters across the ideological spectrum increasingly expect policymakers to distinguish between prudent regulation and heavy-handed bans. When government appears to overreach into personal consumer decisions without clear evidence of benefit, public trust erodes and history has shown that there can be electoral consequences.
None of this is meant to suggest questions surrounding the regulation of kratom or 7-OH should be approached without thoughtful consideration, but the policy question ultimately centers on how government responds to adult consumer choices. Continued research, public education, and sensible guardrails are essential. But a reflexive prohibition approach risks solving little while creating new problems — from black-market activity to reduced consumer transparency.
Freedom and responsibility go hand in hand. That principle should guide this debate. The role of government is to ensure honesty and safety in the marketplace, not to substitute its judgment for that of every individual consumer. Lawmakers considering kratom bans would do well to remember that important insight.
John Dennis is Chairman of the Republican Liberty Caucus, the oldest continuously-operating organization within the Liberty Republican movement.
